Findings to be Presented at ACC Scientific Sessions Highlight Life-Threatening Gaps in Treatment
NEW ORLEANS, Feb. 28, 2023 – According to a new study from the Family Heart Foundation, a leading research and advocacy organization, 72.2% of high-risk hypercholesterolemia patients never achieve the low-density lipoprotein-cholesterol (LDL-C) thresholds recommended in the 2018 American College of Cardiology/American Heart Association Guideline on the Management of Blood Cholesterol. This may be due to a lack of physician prescribing, insurance coverage and patient follow through, despite the known risk of cardiovascular disease. Based on real-world data from an analysis of the Family Heart DatabaseTM of more than 300 million Americans, the findings will be highlighted in a poster presentation at the American College of Cardiology 2023 Conference on March 4, 2023 at 12:45 pm at the Ernest N. Morial Convention Center in New Orleans (Poster Hall – Hall F).
Findings to be Presented at ACC Scientific Sessions Highlight Life-Threatening Gaps in Treatment
Findings to be Presented at ACC Scientific Sessions Highlight Life-Threatening Gaps in Treatment
- Only 27.8% of all high-risk patients ever reached below-guideline LDL-C thresholds.
- For those with episodes below LDL-C thresholds, mean duration of each episode was 158.8 days.
- 79.5% of clinicians never prescribed combination cholesterol-lowering medications though the guideline provides direction and rational for doing so.
- Only 2.2% of high-risk patients received combination cholesterol-lowering medications.
